Search research articles
Contact Us
Filters
Showing results (21-30 of 173) with videos related to
Page
of 18
Sort By:
Antiviral Therapy
|
November 13, 2004
HPV proteins as targets for therapeutic intervention
Helena Sterlinko Grm, Lawrence Banks
Journal of Virology
|
November 24, 2012
High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner
Siaw Shi Boon, Lawrence Banks
The Journal of General Virology
|
September 28, 2004
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Helena Sterlinko Grm, Lawrence Banks
The FEBS Journal
|
September 7, 2021
Spotlight on COVID-19: eighteen months on
Serena Zacchigna, Alessandro Marcello, Lawrence Banks
International Journal of Molecular Sciences
|
September 6, 2018
Papillomaviruses and Endocytic Trafficking
Abida Siddiqa, Justyna Broniarczyk, Lawrence Banks
Virology
|
August 25, 2009
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Vjekoslav Tomaić, David Pim, Lawrence Banks
The Journal of General Virology
|
January 25, 2002
Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation
Daniela Gardiol, Silvina Galizzi, Lawrence Banks
The Journal of General Virology
|
October 15, 2019
Identification of E6AP-independent degradation targets of HPV E6
Arushi Vats, Jayashree Thatte, Lawrence Banks
The Journal of General Virology
|
March 22, 2002
Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins
Agnieszka Bernat, Paola Massimi, Lawrence Banks
Journal of Virology
|
July 31, 2009
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein
David Pim, Vjekoslav Tomaic, Lawrence Banks
Page
of 18
Search research articles
Search
Showing results (21-30 of 173) with videos related to
Sort By:
Page
of 18
Antiviral Therapy
|
November 13, 2004
HPV proteins as targets for therapeutic intervention
Helena Sterlinko Grm, Lawrence Banks
Journal of Virology
|
November 24, 2012
High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner
Siaw Shi Boon, Lawrence Banks
The Journal of General Virology
|
September 28, 2004
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Helena Sterlinko Grm, Lawrence Banks
The FEBS Journal
|
September 7, 2021
Spotlight on COVID-19: eighteen months on
Serena Zacchigna, Alessandro Marcello, Lawrence Banks
International Journal of Molecular Sciences
|
September 6, 2018
Papillomaviruses and Endocytic Trafficking
Abida Siddiqa, Justyna Broniarczyk, Lawrence Banks
Virology
|
August 25, 2009
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Vjekoslav Tomaić, David Pim, Lawrence Banks
The Journal of General Virology
|
January 25, 2002
Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation
Daniela Gardiol, Silvina Galizzi, Lawrence Banks
The Journal of General Virology
|
October 15, 2019
Identification of E6AP-independent degradation targets of HPV E6
Arushi Vats, Jayashree Thatte, Lawrence Banks
The Journal of General Virology
|
March 22, 2002
Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins
Agnieszka Bernat, Paola Massimi, Lawrence Banks
Journal of Virology
|
July 31, 2009
The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein
David Pim, Vjekoslav Tomaic, Lawrence Banks
Page
of 18